anmelden
FTSE All-Share
5.504,53
PKT
-21,74
PKT
-0,39
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 28.03.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 27.03.25 | HSBC Buy | Goldman Sachs Group Inc. | |
| 26.03.25 | Diageo Buy | Jefferies & Company Inc. | |
| 26.03.25 | Shell (ex Royal Dutch Shell) Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.03.25 | Rio Tinto Kaufen | DZ BANK | |
| 26.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 26.03.25 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 26.03.25 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 26.03.25 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 26.03.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 25.03.25 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 25.03.25 | Glencore Outperform | RBC Capital Markets | |
| 25.03.25 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 25.03.25 | London Stock Exchange (LSE) Overweight | JP Morgan Chase & Co. | |
| 25.03.25 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 25.03.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 25.03.25 | GSK Hold | Deutsche Bank AG | |
| 25.03.25 | HSBC Neutral | JP Morgan Chase & Co. | |
| 25.03.25 | Unilever Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.03.25 | London Stock Exchange (LSE) Buy | UBS AG | |
| 20.03.25 | HSBC Sector Perform | RBC Capital Markets | |
| 19.03.25 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 19.03.25 | BAT Neutral | JP Morgan Chase & Co. | |
| 19.03.25 | Diageo Neutral | JP Morgan Chase & Co. | |
| 19.03.25 | Unilever Overweight | JP Morgan Chase & Co. | |
| 18.03.25 | Diageo Neutral | JP Morgan Chase & Co. | |
| 18.03.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 18.03.25 | Unilever Overweight | JP Morgan Chase & Co. | |
| 18.03.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 17.03.25 | AstraZeneca Outperform | Bernstein Research | |
| 17.03.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 17.03.25 | AstraZeneca Buy | UBS AG | |
| 17.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 17.03.25 | Unilever Underperform | Jefferies & Company Inc. | |
| 13.03.25 | Diageo Outperform | Bernstein Research | |
| 12.03.25 | AstraZeneca Buy | UBS AG | |
| 12.03.25 | BP Buy | UBS AG | |
| 12.03.25 | BP Buy | UBS AG | |
| 11.03.25 | National Grid Buy | Jefferies & Company Inc. | |
| 11.03.25 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. |